Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
139 tokens/sec
GPT-4o
7 tokens/sec
Gemini 2.5 Pro Pro
46 tokens/sec
o3 Pro
4 tokens/sec
GPT-4.1 Pro
38 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Diagnosis and Prognosis of Head and Neck Cancer Patients using Artificial Intelligence (2306.00034v1)

Published 31 May 2023 in eess.IV and cs.CV

Abstract: Cancer is one of the most life-threatening diseases worldwide, and head and neck (H&N) cancer is a prevalent type with hundreds of thousands of new cases recorded each year. Clinicians use medical imaging modalities such as computed tomography and positron emission tomography to detect the presence of a tumor, and they combine that information with clinical data for patient prognosis. The process is mostly challenging and time-consuming. Machine learning and deep learning can automate these tasks to help clinicians with highly promising results. This work studies two approaches for H&N tumor segmentation: (i) exploration and comparison of vision transformer (ViT)-based and convolutional neural network-based models; and (ii) proposal of a novel 2D perspective to working with 3D data. Furthermore, this work proposes two new architectures for the prognosis task. An ensemble of several models predicts patient outcomes (which won the HECKTOR 2021 challenge prognosis task), and a ViT-based framework concurrently performs patient outcome prediction and tumor segmentation, which outperforms the ensemble model.

Summary

  • The paper presents a transformer-based tumor segmentation method, achieving a Dice coefficient of 0.736 on the HECKTOR dataset.
  • The paper introduces an ensemble Deep Fusion Model combining radiomic and clinical data to deliver survival predictions with a C-index of 0.72.
  • The paper proposes a Transformer-based Multimodal framework (TMSS) that jointly executes segmentation and prognosis, attaining a C-index of 0.763 and DSC of 0.772.

Advanced Artificial Intelligence Approaches for Head and Neck Cancer Analysis

The research presented in this paper investigates advanced applications of AI in the automated diagnosis and prognosis of head and neck (H&N) cancer, a significant medical challenge due to its prevalence and impact on morbidity and mortality worldwide. The paper details two innovative approaches to H&N tumor analysis utilizing deep learning frameworks: tumor segmentation and patient outcome prediction.

Tumor Segmentation Strategy

To address tumor segmentation, the authors explore the application of a Vision Transformer (ViT)-based model dubbed UNETR, designed specifically for volumetric medical data analysis. They extend the traditional CNN-based segmentation methods, notably U-Net and its variations, by employing a transformer architecture to capture long-range spatial dependencies more effectively. This approach marks a deviation from conventional practices dominated by CNNs, asserting that transformers can rival these models in performance when applied to challenging medical imaging tasks.

Experimental results indicate that the transformer-based architecture approaches competitive performance benchmarks with a Dice Similarity Coefficient (DSC) of 0.736 on the HECKTOR dataset, which is commendably proximate to top-performing CNN models. Variations in performance under different data augmentation regimes underscore the adaptability and robustness of the proposed model.

Moreover, the paper proposes a novel "super images" methodology which reinterprets 3D medical imaging data as 2D constructs, allowing the use of efficient 2D-segmentation models. This approach leverages the widespread success of 2D Convolutional Neural Networks (CNNs) by bridging the gap with 3D data, maintaining competitive segmentation accuracy while significantly reducing computational overhead.

Prognosis Prediction Models

For the prognosis of H&N cancer, two distinct modeling strategies are presented, emphasizing the integration of clinical and imaging data. The first leverages an ensemble method combining Multi-task Logistic Regression (MTLR), Cox Proportional Hazard models, and CNNs—termed Deep Fusion Model. This ensemble strategically fuses radiomic features with clinical data, thereby enhancing the reliability of survival predictions. The approach was validated by winning the HECKTOR challenge with a C-index of 0.72.

Furthermore, the authors propose an end-to-end Transformer-based Multimodal segmentation and survival prediction framework named TMSS. TMSS exploits the multimodal nature of H&N cancer data, incorporating both EHR and medical imaging inputs in an integrated model, thereby simultaneously addressing tumor segmentation and survival prediction tasks. Achieving a C-index of 0.763 and DSC of 0.772, the TMSS model not only excels in prognosis performance but also challenges the notion of isolated task handling, highlighting the potential for integrated, multitask frameworks.

Implications and Future Directions

The research has several profound implications for medical AI applications. By aligning transformer-based architectures with medical imaging tasks, the paper paves the way for further research into transformer models' capability to extract and utilize comprehensive contextual information. This shift could prompt greater adoption of transformers in fields traditionally dominated by CNNs, especially where data is volumetrically complex.

The "super images" approach suggests a pivotal shift in the data dimensionality handling, presenting a hybrid solution bridging 2D and 3D methodologies, facilitating rapid adoption, and reducing computational costs. While the approach has shown efficacy for H&N cancer, its application to other medical imaging tasks could significantly extend its utility.

Future research directions may include the exploration of self-supervised learning (SSL) for pretraining on expansive medical datasets, further hybridization of data modalities within transformer architectures, and broader application of the "super images" conceptual framework across various imaging modalities and clinical contexts. Additionally, validating these models in clinical settings and expanding datasets could enhance robustness, generalization capabilities, and clinical adoption, contributing broadly to personalized medicine and precision oncology.

Youtube Logo Streamline Icon: https://streamlinehq.com